Relationship between postmenopausal hormone replacement therapy and ovarian cancer

被引：20

作者：

Bosetti, C ^{[1
]}

Negri, E

Franceschi, S

Trichopoulos, D

Beral, V

La Vecchia, C

机构：

[1] Ist Ric Farmacol Mario Negri, Milan, Italy

[2] Int Agcy Res Canc, F-69372 Lyon, France

[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[4] Harvard Univ, Sch Publ Hlth, Ctr Canc Prevent, Boston, MA 02115 USA

[5] Univ Oxford, Radcliffe Infirm, Imperial Canc Res Fund, Canc Epidemiol Unit, Oxford OX1 2JD, England

[6] Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 285卷 / 24期

关键词：

D O I：

10.1001/jama.285.24.3089

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3089 / 3089

页数：1

共 8 条

[1]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[2] RISK-FACTORS FOR OVARIAN-CANCER - A CASE CONTROL STUDY [J].

BOOTH, M ;

BERAL, V ;

SMITH, P .

BRITISH JOURNAL OF CANCER, 1989, 60 (04) :592-598

[3]

LAVECCHIA C, IN PRESS MATURITAS

[4]

Negri E, 1999, INT J CANCER, V80, P848

[5] Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women [J].

Rodriguez, C ;

Patel, AV ;

Calle, EE ;

Jacob, EJ ;

Thun, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11) :1460-1465

[6]

Tavani A, 2001, INT J CANCER, V91, P407, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1065>3.3.CO

[7]

2-D

[8] THE EPIDEMIOLOGY OF OVARIAN-CANCER IN GREECE - A CASE-CONTROL STUDY [J].

TZONOU, A ;

DAY, NE ;

TRICHOPOULOS, D ;

WALKER, A ;

SALIARAKI, M ;

PAPAPOSTOLOU, M ;

POLYCHRONOPOULOU, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08) :1045-1052

← 1 →